Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2).
暂无分享,去创建一个
Hidehiko Takahashi | T. Suhara | Y. Okubo | Hiroshi Ito | Hironobu Fujiwara | H. Takano | R. Arakawa | F. Kodaka | T. Nagashima | T. Ichimiya | K. Takahata | Yasuyuki Kimura | T. Nogami | H. Shimada | H. Fukuda | Masayuki Suzuki | Takaaki Mori | Amane Tateno | Takeshi Sasaki | M. Sekine | Tsuyoshi Nogami | Tomohisa Nagashima
[1] Hidehiko Takahashi,et al. Norepinephrine transporter occupancy by antidepressant in human brain using positron emission tomography with (S,S)-[18F]FMeNER-D2 , 2010, Psychopharmacology.
[2] R. Carson,et al. PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)‐[11C]O‐methylreboxetine and HRRT , 2010, Synapse.
[3] Hidehiko Takahashi,et al. Quantitative Analysis of Norepinephrine Transporter in the Human Brain Using PET with (S,S)-18F-FMeNER-D2 , 2008, Journal of Nuclear Medicine.
[4] Christer Halldin,et al. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET , 2008, NeuroImage.
[5] R. Shelton,et al. Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents , 2007, Biological Psychiatry.
[6] M. Thase,et al. Efficacy of Duloxetine and Selective Serotonin Reuptake Inhibitors: Comparisons as Assessed by Remission Rates in Patients With Major Depressive Disorder , 2007, Journal of clinical psychopharmacology.
[7] Masanori Ichise,et al. Elevated Serotonin Transporter Binding in Major Depressive Disorder Assessed Using Positron Emission Tomography and [11C]DASB; Comparison with Bipolar Disorder , 2007, Biological Psychiatry.
[8] M. Mimura,et al. Effect of high-dose milnacipran in patients with depression , 2007, Neuropsychiatric disease and treatment.
[9] N. Volkow,et al. Imaging the norepinephrine transporter in humans with (S,S)-[11C]O-methyl reboxetine and PET: problems and progress. , 2007, Nuclear medicine and biology.
[10] R. P. Maguire,et al. Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] Ramin V. Parsey,et al. Acute Occupancy of Brain Serotonin Transporter by Sertraline as Measured by [11C]DASB and Positron Emission Tomography , 2006, Biological Psychiatry.
[12] S. Tanada,et al. A dose-finding study of duloxetine based on serotonin transporter occupancy , 2006, Psychopharmacology.
[13] Sylvain Houle,et al. Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? , 2005, Nuclear medicine and biology.
[14] Sylvain Houle,et al. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. , 2004, Archives of general psychiatry.
[15] K. Kanemoto,et al. Controlled comparison of two different doses of milnacipran in major depressive outpatients , 2004, International clinical psychopharmacology.
[16] B. Gulyás,et al. PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain , 2004, Synapse.
[17] F. Bymaster,et al. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats , 2003, Neuropharmacology.
[18] C. Nemeroff,et al. Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity , 2003, Biological Psychiatry.
[19] Yoshiro Okubo,et al. High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography. , 2003, Archives of general psychiatry.
[20] S. Tanada,et al. Age-related decline of serotonin transporters in living human brain of healthy males. , 2002, Life sciences.
[21] F. Yasuno,et al. Serotonin transporter binding in patients with mood disorders: a PET study with [11C](+)McN5652 , 2002, Biological Psychiatry.
[22] D. Wong,et al. Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo, Human Serotonin Receptor Subtypes, and Other Neuronal Receptors , 2001, Neuropsychopharmacology.
[23] Alan A. Wilson,et al. Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. , 2001, The American journal of psychiatry.
[24] Alan A. Wilson,et al. Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB , 2000, European Journal of Nuclear Medicine.
[25] S. Houle,et al. Novel Radiotracers for Imaging the Serotonin Transporter by Positron Emission Tomography: Synthesis, Radiosynthesis, and in Vitro and ex Vivo Evaluation of (11)C-Labeled 2-(Phenylthio)araalkylamines. , 2000, Journal of medicinal chemistry.
[26] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[27] Y. Lecrubier,et al. Clinical efficacy of milnacipran: placebo‐controlled trials , 1996, International clinical psychopharmacology.
[28] S. Kasper,et al. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results , 1996, International clinical psychopharmacology.
[29] G. Paxinos,et al. Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H] mazindol autoradiography , 1991, The Journal of comparative neurology.
[30] J. Téllez-Zenteno,et al. Neuropsychiatric Disease and Treatment Epilepsy and homicide , 2013 .
[31] T. Furukawa,et al. Remission Rates with Milnacipran 100 Mg/Day and 150 Mg/Day in the Long- Term Treatment of Major Depression , 2006, Clinical drug investigation.
[32] C. Halldin,et al. Short communication Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-( 18 F)FMeNER-D 2 , 2005 .
[33] I. Anderson. SSRIs versus tricyclic antidepressants in depressed inpatients: A meta‐analysis of efficacy and tolerability , 1998, Depression and anxiety.
[34] M. Ansseau,et al. Pooling two controlled comparisons of milnacipran (F2207) and amitriptyline in endogenous inpatients. A new approach in dose ranging studies. , 1990, International clinical psychopharmacology.